Factors Contributing to Successful Transvenous Retrograde Thoracic Duct Cannulation

J Vasc Interv Radiol. 2023 Feb;34(2):205-211. doi: 10.1016/j.jvir.2022.10.037. Epub 2022 Oct 29.

Abstract

Purpose: To identify key factors for successful transvenous retrograde cannulation (TVRC) of the thoracic duct.

Materials and methods: A total of 47 consecutive patients (62.1 ± 13.2 years; 32 men) who underwent attempted TVRC between July 2016 and July 2021 were included. Reasons for interventions were chylous leakage from the chest (n = 36), abdomen (n = 6), and other sites (n = 5). Patient age, sex, access vein (femoral vs brachial), anatomic classification (presence of dominant channel vs plexiform) of the terminal thoracic duct, and engagement of a diagnostic catheter into the jugulovenous junction were included in the analyses. Anatomic details were evaluated according to catheter-based high-pressure lymphangiography and conventional intranodal lymphangiography. The Firth bias-reduced penalized-likelihood logistic regression model was used to analyze prognostic factors.

Results: TVRC was successful in 33 of the 47 patients (70%). In univariate analysis, femoral access, diagnostic catheter engagement, and presence of dominant channel were significant positive prognostic factors (P <.05). In multivariate analysis, diagnostic catheter engagement and presence of dominant channel were significant prognostic factors (P <.05). Diagnostic catheter engagement showed the highest prognostic performance (accuracy = 0.872), followed by presence of a dominant channel. High-pressure catheter-based lymphangiographic findings showed better performance (accuracy, 0.844 vs 0.727) than intranodal lymphangiography to delineate the anatomy of the terminal thoracic duct.

Conclusions: A secure selection of the jugulovenous junction and the presence of a dominant channel in the terminal portion of the thoracic duct were significant prognostic factors for successful TVRC.

MeSH terms

  • Catheterization
  • Catheters
  • Chylothorax* / diagnostic imaging
  • Chylothorax* / therapy
  • Embolization, Therapeutic*
  • Humans
  • Lymphography
  • Male
  • Thoracic Duct / diagnostic imaging